The complete positive results from the Phase III Crossing study showed that tezepelumab achieved statistically significant and clinically relevant improvements in the co-primary endpoints of ...
(Adnkronos Health) - "The important results of the Crossing study further support the broad potential of tezepelumab and its unique mechanism of action, which acts on TSLP at the origin of the ...
This gives developers the flexibility to build around their team's processes and connect GeeLark with the software that ...
Kawasaki, Nagoya, Yokosuka and Tokyo, Japan, October 21, 2026 - (JCN Newswire) - Fujitsu Limited[1] (Fujitsu), Nagoya ...
The closing day of the 2026 IFS Unleashed conference in Orlando saw the host of the Extraordinary Life Stories podcast, John ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results